Jeld-Wen (NYSE:JELD) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Company ParticipantsBill Christensen - CEOJames Armstrong - VP of Investor RelationsSamantha Stoddard - CFOConference Call ParticipantsSusan Maklari - Senior Equity Research AnalystOperatorLadies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome you to the JELD-WEN's fourth quarter and full year 2025 earnings conference call. All lines have b ...

Insulet (NasdaqGS:PODD) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Company ParticipantsAshley McEvoy - President and CEOClare Trachtman - VP of Investor RelationsEric Benjamin - COOFlavia Pease - CFOJoanne Wuensch - Managing DirectorConference Call ParticipantsDanielle Antalffy - Managing Director and Senior Equity Research AnalystDavid Roman - Managing Director and Senior AnalystJeff Johnson - Managing Director and Senior Research AnalystLarry Biegelsen - Managing Director and Senior AnalystMichae ...

Financial Data and Key Metrics Changes - The company reported strong financial results for Q4 2025, indicating progress in its transformation despite some tailwinds [4][5] - The foundation of the business was significantly strengthened in 2025 through leadership upgrades, structural simplification, and cost elimination [5] Business Line Data and Key Metrics Changes - The presort business has seen new customer wins and no churn since June 2025, with a full pipeline of sales expected to translate into financial results over the coming months [8][10] - The company is focusing on being more aggressive with pricing in the presort business to win back clients and expects EBIT margins in the low-to-mid 20% range [14][16] Market Data and Key Metrics Changes - The company acknowledged potential headwinds from government shutdowns and economic uncertainties, particularly affecting the SendTech space [7] - The SendTech business is expected to experience a top-line decline in 2026, but the second half of the year is anticipated to be stronger than the first half [24][26] Company Strategy and Development Direction - The company is pivoting towards profitable growth and is undergoing an external review with qualified advisors [5] - There is a renewed focus on mail and investment to slow the decline in certain business areas, particularly in the presort and shipping segments [65] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery from the low point tied to the IMI migration, with expectations for gradual improvement in the SendTech business [50] - The company is optimistic about growth opportunities in presort, shipping, and the bank, with a focus on capital allocation and maintaining a net debt to EBITDA ratio around 3x [66][68] Other Important Information - The company plans to hold an investor day in 2026 to enhance education on its business fundamentals [66] - Management emphasized the importance of building a strong foundation for future growth, despite short-term challenges [72] Q&A Session Summary Question: Can you expand on the additional market uncertainty and geopolitical challenges? - Management highlighted issues like government shutdowns and economic direction uncertainties, particularly affecting the presort business [7] Question: What impact did the government shutdown have in the quarter? - The CFO noted that hardware purchases were impacted, pushing some sales into the subsequent quarter [13] Question: How aggressive will the pricing strategy be in the presort business? - Management indicated that they are now being more aggressive to win new customers and have already made concessions to existing clients [14][15] Question: Will the second half of the year show positive growth in the presort business? - The CFO mentioned that while the first half will be challenging, the second half is expected to be a better comp year [23] Question: What are the growth opportunities for the company moving forward? - Management identified presort, shipping, and banking as key areas for growth, emphasizing a focus on capital allocation [65][66]

Financial Data and Key Metrics Changes - Fourth quarter net revenue was $802 million, down 10% year-over-year from $896 million in the prior year, with core revenue declining 8% primarily due to lower volume [13][16] - Adjusted EBITDA for the quarter was $15 million, or 1.8% of sales, compared to $40 million, or 4.5% of sales in the fourth quarter of last year, reflecting unfavorable operating leverage and ongoing price and cost pressures [13][18] - For the full year, sales totaled $3.2 billion and Adjusted EBITDA was $120 million, which was at the high end of guidance but below initial expectations [8][12] Business Line Data and Key Metrics Changes - In North America, fourth quarter revenue was $522 million, down from $640 million in the prior year, with Adjusted EBITDA declining to $14 million from $42 million [19] - In Europe, revenue increased to $280 million from $256 million in the prior year, primarily due to a weaker US dollar, but volumes and mix were lower year-over-year [19][20] Market Data and Key Metrics Changes - The overall market for windows and doors in North America is expected to decline low- to mid-single digits, with new single-family construction down low single digits and repair and remodel activity down mid-single digits [21][24] - The Canadian market is anticipated to see high single-digit declines due to ongoing economic slowdown and weaker housing activity [21] - In Europe, volumes are expected to be broadly flat year-over-year, indicating stabilization without material improvements [22][23] Company Strategy and Development Direction - The company is focused on controlling costs and improving execution in a challenging macro environment, with structural actions taken to align costs with current market realities [10][11] - A strategic review of the European business is ongoing, with potential actions to improve liquidity and strengthen the balance sheet [10][11] - The company is implementing a new A3 Operating System across its manufacturing network to improve problem-solving and operational consistency [31][32] Management's Comments on Operating Environment and Future Outlook - Management noted that the macro environment remained soft, with no meaningful improvement in demand expected in the near term [4][10] - The company is prioritizing pricing discipline and expects to face continued headwinds from cost inflation, particularly in tariffs and materials [24][28] - Management expressed confidence in the company's ability to operate from a stronger position as market conditions improve, focusing on service and operational improvements [12][34] Other Important Information - The company completed a sale-leaseback of its Coral Springs facility, generating approximately $38 million in net proceeds, enhancing liquidity [6][15] - At year-end, the company had approximately $136 million in cash and about $350 million available on its revolver, with no debt maturities until December 2027 [11] Q&A Session Summary Question: Price versus volume dynamic - Management indicated that pricing actions are largely implemented and expect slight headwinds from price-cost dynamics due to ongoing inflation [42][43] Question: Implementation of operational improvements - Management reported that they are approximately 85% through the implementation of the new operating model across all sites, focusing on shop floor improvements and productivity [46][47]

SolarEdge Technologies (NasdaqGS:SEDG) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Speaker10This call is being webcast live on the company's website at www.solaredge.com in the Investors section on the Events Calendar page. This call is the sole property and copyright of SolarEdge, with all rights reserved, and any recording, reproduction, or transmission of this call without the express written consent of SolarEdge is prohibited. You may listen to a webcast replay of this call by visiting the Event ...

Global-E Online (NasdaqGS:GLBE) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Speaker8Good morning. Welcome to the Global-e fourth quarter and full year 2025 earnings call. This call is being simultaneously webcast on the company's website in the Investors section under News and Events. For opening remarks and introductions, I will now turn the call over to Alan Katz, Global-e's Head of Investor Relations. Please go ahead.Speaker0Thank you, and good morning, everyone. With me on the call today are Ami ...

Global Payments (NYSE:GPN) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Speaker12Ladies and gentlemen, thank you for standing by, and welcome to Global Payments' fourth quarter and full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. Later, we will open the lines for questions and answers. As a reminder, today's conference will be recorded. At this time, I would like to turn the conference over to your host, Senior Vice President, Investor Relations, Nath ...

Bausch + Lomb (NYSE:BLCO) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Speaker9Please note this event is being recorded. I would now like to turn the conference over to George Gadkowski, Vice President of Investor Relations and Business Insights. Please go ahead.Speaker4Thank you. Good morning, everyone, and welcome to our fourth quarter 2025 financial results conference call. Participating on today's call are Chairman and Chief Executive Officer, Mr. Brent Saunders, Chief Financial Officer, Mr. Sam ...

Pitney Bowes (NYSE:PBI) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Speaker7Ladies and gentlemen, thank you for standing by. Welcome to the fourth quarter 2025 Pitney Bowes Earnings Conference Call. Joining us today are Chief Executive Officer Kurt Wolf, Chief Financial Officer Paul Evans, and Director Investor Relations Alex Brown. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the ses ...

Financial Data and Key Metrics Changes - The company reported total revenues of $784 million for Q4 2025, representing a 29% increase in constant currency [5][25] - Full year revenues surpassed $2.7 billion, more than doubling the revenue base over the last three years, with approximately 30% year-over-year constant currency growth [5][25] - Adjusted EPS for Q4 was $1.55, a 35% increase from $1.15 in the prior year, while full year adjusted EPS was $4.97, up 53% from $3.24 [32] Business Line Data and Key Metrics Changes - U.S. revenues for Q4 were $568 million, up 28%, while international revenues reached $214 million, growing 42% in constant currency [5][25] - Total Omnipod revenue grew 31.3% on a constant currency basis in Q4, and 30.3% for the full year [25][26] - The U.S. Omnipod revenue grew 28% in Q4 and 27.2% for the year, driven by demand for Omnipod 5 across Type 1 and Type 2 customers [26][27] Market Data and Key Metrics Changes - The U.S. Type 1 market is valued at over $9 billion, with AID penetration at just 40%, indicating significant growth potential [8] - The Type 2 market exceeds $12 billion, with AID penetration below 5%, presenting a substantial opportunity for expansion [10] - Internationally, the Type 1 market exceeds $10 billion, with only one in four people with diabetes using AID therapy, highlighting a large under-penetrated market [14] Company Strategy and Development Direction - The company aims to maintain its leadership position in AID and expand its market share by focusing on innovation and clinical outcomes [7][18] - Plans include launching a fully closed loop system for Type 2 diabetes by 2028, which is expected to significantly increase market penetration [11][22] - The company is committed to investing in R&D, with a projected $1 billion investment over the next three years to support innovation and market expansion [72] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to sustain top-tier growth and value creation for shareholders, supported by a strong financial position and competitive advantages [15][24] - The company anticipates continued growth in 2026, with guidance for Omnipod revenue growth of 21%-23% and total company revenue growth of 20%-22% [36][37] - Management acknowledged potential challenges in sustaining growth due to anniversarying the first full year of the U.S. launch of Omnipod for Type 2 and annualizing several international launches [36] Other Important Information - The company achieved record new customer starts across both U.S. and international markets, with a significant portion coming from patients transitioning from multiple daily injections [6][26] - The company has built strong relationships with payers and PBMs, ensuring broad access to its products, available in approximately 48,000 U.S. pharmacies [12] - The company ended the quarter with $760 million in cash and delivered over $375 million in free cash flow for 2025, a 24% increase over the previous year [33] Q&A Session Summary Question: What is the most underappreciated part of the Insulet story from an investor perspective? - Management highlighted four key areas: technology leadership, growing commercial prowess, manufacturing at scale, and financial strength [44][45] Question: How are new patient start trends in the U.S. and outside the U.S.? - Management reported record new customer starts in both markets, with a significant portion coming from patients on multiple daily injections [51][53] Question: Can you help reconcile script trends to reported revenue? - Management advised that total pods are the best reflection of future revenue outlook, with total scripts as a secondary option [58][60] Question: How does the company plan to sustain growth amid new competition? - Management emphasized the barriers to entry in the market, including manufacturing at scale and the need for continued innovation [66][68]